序号 |
标题 |
次数 |
作者 |
发布时间 |
86221 |
CAS:137076-54-1 三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
134 |
zyl |
2024-11-28 |
86222 |
3,6-双(1H-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
135 |
WYQ |
2024-11-28 |
86223 |
3-甲基-5-芳基吡唑,3,4−e 并-1,2,3,4-四嗪衍生物 |
128 |
WYQ |
2024-11-28 |
86224 |
β-环糊精改性聚对二氧环己酮/聚乙烯醇水凝胶 β-CD-PPDO/PVA |
175 |
h |
2024-11-28 |
86225 |
DOTA-PAMAMG3.0-SH ,DOTA-PAMAMG3.0-巯基, DOTA偶联巯基化聚酰胺-胺(PAMAM)树形分子 |
135 |
kx |
2024-11-28 |
86226 |
3,3′-偶氮-1,2,4,5-四嗪衍生物 |
120 |
WYQ |
2024-11-28 |
86227 |
β-环糊精/Fe3O4/氧化石墨烯 |
142 |
h |
2024-11-28 |
86228 |
DOTA-PEG-CRGD环肽;大环配体DOTA-聚乙二醇-CRGD |
107 |
zcy |
2024-11-28 |
86229 |
3,6-二胍基-1,2,4,5-四嗪(DGTz) |
155 |
WYQ |
2024-11-28 |
86230 |
β-环糊精-聚丙烯酰胺水凝胶 β-CD-PAM |
184 |
h |
2024-11-28 |
86231 |
Iron DOTA Sodium Salt |
134 |
zyl |
2024-11-28 |
86232 |
环糊精-聚丙烯酸复合水凝胶 β-CD/PAA |
164 |
h |
2024-11-28 |
86233 |
3,6-二肼基-1,2,4,5-四嗪(DHTz) |
139 |
WYQ |
2024-11-28 |
86234 |
DOTA-c(RGDfK);具有特定生物活性的多肽分子 |
115 |
zcy |
2024-11-28 |
86235 |
1,2,3,4-四嗪-1,3-二氧化物 |
125 |
WYQ |
2024-11-28 |
86236 |
3,6-双(1H-1,2,4-三唑-3-氨基)-1,2,4,5-四嗪 |
113 |
WYQ |
2024-11-28 |
86237 |
3,6-双-(3,5-二氨基-1,2,4-三唑基)-1,2,4,5-四嗪(BTDTz) |
125 |
WYQ |
2024-11-28 |
86238 |
β-环糊精交联聚丙烯酸水凝胶 β-CD-6-A |
111 |
h |
2024-11-28 |
86239 |
DOTA-Tyr-3/temozolomide ,Dota-Tyr-3/替莫唑胺 |
112 |
kx |
2024-11-28 |
86240 |
3,6-二氯-1,2,4,5-四嗪(BCT) |
148 |
WYQ |
2024-11-28 |
86241 |
大豆多糖/β-环糊精三维纳米水凝胶 SSPS/β-CD |
144 |
h |
2024-11-28 |
86242 |
DOTA-3-酪氨酰基-奥曲肽,多肽化合物177943-89-4 |
101 |
zcy |
2024-11-28 |
86243 |
180978-54-5,DOTA-p-NH2-Bn-Biotin,DOTA-生物素-肌氨酸 |
109 |
zcy |
2024-11-28 |
86244 |
DOTA-Ala-Ala-Tyr-COOH;DOTA-丙氨酸-丙氨酸-酪氨酸-羧酸 |
115 |
zcy |
2024-11-28 |
86245 |
Ln-DOTA-Dimedone |
151 |
kx |
2024-11-28 |
86246 |
超亲水性/水下超疏油的纤维素/环糊精基聚电解质刷复合气凝胶 CE/β-CD-g-PDMAEMA |
211 |
h |
2024-11-28 |
86247 |
68Ga-DOTA-cNGR,PET探针 |
215 |
zcy |
2024-11-28 |
86248 |
DOTA-TRI(ACID)-酰胺-三聚乙二醇-溴乙酰胺 |
113 |
zyl |
2024-11-28 |
86249 |
β-环糊精大分子单体/N-异丙基丙烯酰胺共聚水凝胶 MAH-β-CD-EPI |
136 |
h |
2024-11-28 |
86250 |
单克隆抗体的f(ab’)2片段缀合DOTA-PAMAM树枝状聚合物 |
198 |
kx |
2024-11-28 |
86251 |
DOTA-E-[cyclo(RGDfK(Acp))]2;基于NOTADOTA定制和偶联 |
126 |
zcy |
2024-11-28 |
86252 |
石墨烯掺杂的环糊精/支状聚醚水凝胶 |
139 |
h |
2024-11-28 |
86253 |
DOTA-三(酸) - 酰氨基-DPEG(R)12-TFP酯 |
108 |
zyl |
2024-11-28 |
86254 |
3-丙烯酰胺苯硼酸基β-环糊精基聚丙烯酰胺(AAPBA-CD)主体水凝胶 |
217 |
h |
2024-11-28 |
86255 |
DOTA-TRIS(TBE)-AMIDO-DPEG(R)12-TFP酯 |
107 |
zyl |
2024-11-28 |
86256 |
DOTA-octreotide,大环配体奥曲肽 |
114 |
zcy |
2024-11-28 |
86257 |
(DOTA)3-十氢赖氨酸 , (DOTA)3-decalysine |
96 |
kx |
2024-11-28 |
86258 |
DOTA-CH2-Alkynyl (TFA salt),1189194-65-7,基于NOTADOTA定制和偶联 |
98 |
zcy |
2024-11-28 |
86259 |
聚异丙基丙烯酰胺-聚乙二醇/α-环糊精水凝胶 PEG-b-PNIPAM/α-CD |
159 |
h |
2024-11-28 |
86260 |
DOTA-E-[c(RGD fk)] ,DOTA修饰双环肽E[c(RGDfK)] |
106 |
kx |
2024-11-28 |
86261 |
BUTYNE-DOTA 炔基 |
109 |
zyl |
2024-11-28 |
86262 |
CAS号:508172-24-5 Lysine-DOTA |
144 |
zyl |
2024-11-28 |
86263 |
DOTA-CNS-cNGR ,DOTA-纳米球-肽缀合物 |
119 |
kx |
2024-11-28 |
86264 |
CAS:1670260-54-4 DOTA-tris(t-Bu)-Amido-PEG7-Azide |
169 |
zyl |
2024-11-28 |
86265 |
丁香酚β-环糊精/羧甲基纤维素钠水凝胶 EG-β-CD/CMC hydrogel |
158 |
h |
2024-11-28 |